Global Cancer Therapeutics Biotherapeutic Market Dynamics: Clinical Pipeline and Commercialization
Cancer is increasingly recognized not as a single disease, but as a diverse collection of molecularly distinct conditions driven by complex genetic variations. Consequently, standardized oncology protocols are rapidly giving way to precision medicine, where therapeutic selection depends entirely on a patient's individual genomic profile, biomarker expression, and immune status. This paradigm...
0 Comments 0 Shares 23 Views 0 Reviews